{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:17:07Z","timestamp":1790615827713,"version":"4.1.0"},"reference-count":77,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T00:00:00Z","timestamp":1544486400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1122952"],"award-info":[{"award-number":["APP1122952"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1117510"],"award-info":[{"award-number":["APP1117510"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns4:p>By definition, congenital myopathy typically presents with skeletal muscle weakness and hypotonia at birth. Traditionally, congenital myopathy subtypes have been predominantly distinguished on the basis of the pathological hallmarks present on skeletal muscle biopsies. Many genes cause congenital myopathies when mutated, and a burst of new causative genes have been identified because of advances in gene sequencing technology. Recent discoveries include extending the disease phenotypes associated with previously identified genes and determining that genes formerly known to cause only dominant disease can also cause recessive disease. The more recently identified congenital myopathy genes account for only a small proportion of patients. Thus, the congenital myopathy genes remaining to be discovered are predicted to be extremely rare causes of disease, which greatly hampers their identification. Significant progress in the provision of molecular diagnoses brings important information and value to patients and their families, such as possible disease prognosis, better disease management, and informed reproductive choice, including carrier screening of parents. Additionally, from accurate genetic knowledge, rational treatment options can be hypothesised and subsequently evaluated <ns4:italic>in vitro<\/ns4:italic> and in animal models. A wide range of potential congenital myopathy therapies have been investigated on the basis of improved understanding of disease pathomechanisms, and some therapies are in clinical trials. Although large hurdles remain, promise exists for translating treatment benefits from preclinical models to patients with congenital myopathy, including harnessing proven successes for other genetic diseases.<\/ns4:p>","DOI":"10.12688\/f1000research.16422.1","type":"journal-article","created":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T05:25:12Z","timestamp":1544505912000},"page":"1921","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["Recent advances in understanding congenital myopathies"],"prefix":"10.12688","volume":"7","author":[{"given":"Gianina","family":"Ravenscroft","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Bryson-Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen J.","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5111-3732","authenticated-orcid":false,"given":"Nigel G.","family":"Laing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2560","published-online":{"date-parts":[[2018,12,11]]},"reference":[{"key":"ref-1","doi-asserted-by":"publisher","first-page":"160-70","DOI":"10.1016\/j.semcdb.2016.08.002","article-title":"New era in genetics of early-onset muscle disease: Breakthroughs and challenges.","volume":"64","author":"G Ravenscroft","year":"2017","journal-title":"Semin Cell Dev Biol."},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"681-91","DOI":"10.1038\/nrg3555","article-title":"Rare-disease genetics in the era of next-generation sequencing: discovery to translation.","volume":"14","author":"K Boycott","year":"2013","journal-title":"Nat Rev Genet."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"505-14","DOI":"10.1136\/jmedgenet-2018-105266","article-title":"Genetics of neuromuscular fetal akinesia in the genomics era.","volume":"55","author":"S Beecroft","year":"2018","journal-title":"J Med Genet."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"549-64","DOI":"10.1016\/B978-0-444-64076-5.00036-3","article-title":"The genetics of congenital myopathies.","volume":"148","author":"H Gonorazky","year":"2018","journal-title":"Handb Clin Neurol."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"218-26","DOI":"10.1016\/j.ajhg.2014.07.004","article-title":"SPEG interacts with myotubularin, and its deficiency causes centronuclear myopathy with dilated cardiomyopathy.","volume":"95","author":"P Agrawal","year":"2014","journal-title":"Am J Hum Genet."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"e140","DOI":"10.1212\/NXG.0000000000000140","article-title":"Phenotypes, genotypes, and prevalence of congenital myopathies older than 5 years in Denmark.","volume":"3","author":"N Witting","year":"2017","journal-title":"Neurol Genet."},{"key":"ref-7","doi-asserted-by":"publisher","first-page":"28-35","DOI":"10.1212\/WNL.0000000000001110","article-title":"Congenital myopathies: Natural history of a large pediatric cohort.","volume":"84","author":"I Colombo","year":"2015","journal-title":"Neurology."},{"key":"ref-8","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddy320","article-title":"Bi-allelic mutations in MYL1 cause a severe congenital myopathy.","author":"G Ravenscroft","year":"2018","journal-title":"Hum Mol Genet."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"219-27","DOI":"10.3233\/JND-150085","article-title":"A Premature Stop Codon in MYO18B is Associated with Severe Nemaline Myopathy with Cardiomyopathy.","volume":"2","author":"E Malfatti","year":"2015","journal-title":"J Neuromuscul Dis."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"400-4","DOI":"10.1136\/jmedgenet-2014-102964","article-title":"A novel syndrome of Klippel-Feil anomaly, myopathy, and characteristic facies is linked to a null mutation in MYO18B.","volume":"52","author":"A Alazami","year":"2015","journal-title":"J Med Genet."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"467-73","DOI":"10.1002\/ana.24900","article-title":"Recessive MYPN mutations cause cap myopathy with occasional nemaline rods.","volume":"81","author":"X Lornage","year":"2017","journal-title":"Ann Neurol."},{"key":"ref-12","doi-asserted-by":"publisher","first-page":"169-78","DOI":"10.1016\/j.ajhg.2016.11.017","article-title":"Biallelic Mutations in MYPN, Encoding Myopalladin, Are Associated with Childhood-Onset, Slowly Progressive Nemaline Myopathy.","volume":"100","author":"S Miyatake","year":"2017","journal-title":"Am J Hum Genet."},{"key":"ref-13","doi-asserted-by":"publisher","first-page":"666-73","DOI":"10.1016\/j.ajhg.2016.06.021","article-title":"Biallelic PPA2 Mutations Cause Sudden Unexpected Cardiac Arrest in Infancy.","volume":"99","author":"A Guimier","year":"2016","journal-title":"Am J Hum Genet."},{"key":"ref-14","doi-asserted-by":"publisher","first-page":"674-82","DOI":"10.1016\/j.ajhg.2016.06.027","article-title":"Sudden Cardiac Death Due to Deficiency of the Mitochondrial Inorganic Pyrophosphatase PPA2.","volume":"99","author":"H Kennedy","year":"2016","journal-title":"Am J Hum Genet."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"1086-105","DOI":"10.1016\/j.ajhg.2016.09.005","article-title":"Variants in the Oxidoreductase PYROXD1 Cause Early-Onset Myopathy with Internalized Nuclei and Myofibrillar Disorganization.","volume":"99","author":"G O'Grady","year":"2016","journal-title":"Am J Hum Genet."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"841-7","DOI":"10.1111\/ene.13607","article-title":"Ryanodine receptor type 3 (RYR3) as a novel gene associated with a myopathy with nemaline bodies.","volume":"25","author":"Y Nilipour","year":"2018","journal-title":"Eur J Neurol."},{"key":"ref-17","doi-asserted-by":"publisher","first-page":"531-6","DOI":"10.1016\/j.nmd.2017.02.012","article-title":"Cytoplasmic body pathology in severe ACTA1-related myopathy in the absence of typical nemaline rods.","volume":"27","author":"S Donkervoort","year":"2017","journal-title":"Neuromuscul Disord."},{"key":"ref-18","doi-asserted-by":"publisher","first-page":"742-6","DOI":"10.1016\/j.nmd.2017.05.003","article-title":"Autosomal dominant distal myopathy due to a novel ACTA1 mutation.","volume":"27","author":"T Liewluck","year":"2017","journal-title":"Neuromuscul Disord."},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"261-2","DOI":"10.1016\/j.jocn.2018.04.044","article-title":"A novel ACTA1 mutation causing progressive facioscapuloperoneal myopathy in an adult.","volume":"53","author":"J Kao","year":"2018","journal-title":"J Clin Neurosci."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"517-33","DOI":"10.1007\/s00401-016-1656-8","article-title":"Dihydropyridine receptor (DHPR, CACNA1S) congenital myopathy.","volume":"133","author":"V Schartner","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref-21","doi-asserted-by":"publisher","first-page":"1161-72","DOI":"10.1002\/humu.23559","article-title":"De novo mutations in FLNC leading to early-onset restrictive cardiomyopathy and congenital myopathy.","volume":"39","author":"A Kiselev","year":"2018","journal-title":"Hum Mutat."},{"key":"ref-22","doi-asserted-by":"publisher","first-page":"1483-92","DOI":"10.1016\/S0140-6736(18)30021-7","article-title":"Dysfunction of NaV1.4, a skeletal muscle voltage-gated sodium channel, in sudden infant death syndrome: a case-control study.","volume":"391","author":"R M\u00e4nnikk\u00f6","year":"2018","journal-title":"Lancet."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"674-91","DOI":"10.1093\/brain\/awv352","article-title":"Loss-of-function mutations in SCN4A cause severe foetal hypokinesia or 'classical' congenital myopathy.","volume":"139","author":"I Zaharieva","year":"2016","journal-title":"Brain."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"383-8","DOI":"10.1002\/humu.23385","article-title":"Nemaline myopathy and distal arthrogryposis associated with an autosomal recessive TNNT3 splice variant.","volume":"39","author":"S Sandaradura","year":"2018","journal-title":"Hum Mutat."},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"1105-24","DOI":"10.1002\/ana.25241","article-title":"Congenital Titinopathy: Comprehensive characterization and pathogenic insights.","volume":"83","author":"E Oates","year":"2018","journal-title":"Ann Neurol."},{"key":"ref-26","doi-asserted-by":"publisher","first-page":"2051-60","DOI":"10.1161\/CIRCULATIONAHA.115.015397","article-title":"Homozygous\/Compound Heterozygous Triadin Mutations Associated With Autosomal-Recessive Long-QT Syndrome and Pediatric Sudden Cardiac Arrest: Elucidation of the Triadin Knockout Syndrome.","volume":"131","author":"H Altmann","year":"2015","journal-title":"Circulation."},{"key":"ref-27","doi-asserted-by":"publisher","first-page":"1153-6","DOI":"10.1212\/WNL.0000000000003745","article-title":"Congenital myopathy associated with the triadin knockout syndrome.","volume":"88","author":"A Engel","year":"2017","journal-title":"Neurology."},{"key":"ref-28","doi-asserted-by":"publisher","first-page":"151-67","DOI":"10.1038\/nrneurol.2017.191","article-title":"Congenital myopathies: disorders of excitation-contraction coupling and muscle contraction.","volume":"14","author":"H Jungbluth","year":"2018","journal-title":"Nat Rev Neurol."},{"key":"ref-29","doi-asserted-by":"publisher","first-page":"307-14","DOI":"10.3233\/JND-170298","article-title":"An Extended Targeted Copy Number Variation Detection Array Including 187 Genes for the Diagnostics of Neuromuscular Disorders.","volume":"5","author":"L Sagath","year":"2018","journal-title":"J Neuromuscul Dis."},{"key":"ref-30","doi-asserted-by":"publisher","first-page":"1284-98","DOI":"10.1002\/humu.23560","article-title":"Targeted sequencing with expanded gene profile enables high diagnostic yield in non-5q-spinal muscular atrophies.","volume":"39","author":"M Karakaya","year":"2018","journal-title":"Hum Mutat."},{"key":"ref-31","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-017-0006-7","article-title":"Cost-effectiveness of massively parallel sequencing for diagnosis of paediatric muscle diseases.","volume":"2","author":"D Schofield","year":"2017","journal-title":"NPJ Genom Med."},{"key":"ref-32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13023-015-0364-0","article-title":"Next generation sequencing in a large cohort of patients presenting with neuromuscular disease before or at birth.","volume":"10","author":"E Todd","year":"2015","journal-title":"Orphanet J Rare Dis."},{"key":"ref-33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13395-018-0156-z","article-title":"The complexity of titin splicing pattern in human adult skeletal muscles.","volume":"8","author":"M Savarese","year":"2018","journal-title":"Skelet Muscle."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"557-65","DOI":"10.1001\/jamaneurol.2017.4899","article-title":"Interpreting Genetic Variants in Titin in Patients With Muscle Disorders.","volume":"75","author":"M Savarese","year":"2018","journal-title":"JAMA Neurol."},{"key":"ref-35","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal5209","article-title":"Improving genetic diagnosis in Mendelian disease with transcriptome sequencing.","volume":"9","author":"B Cummings","year":"2017","journal-title":"Sci Transl Med."},{"key":"ref-36","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41525-018-0045-8","article-title":"The NSIGHT1-randomized controlled trial: rapid whole-genome sequencing for accelerated etiologic diagnosis in critically ill infants.","volume":"3","author":"J Petrikin","year":"2018","journal-title":"NPJ Genom Med."},{"key":"ref-37","doi-asserted-by":"publisher","first-page":"99-113","DOI":"10.3233\/JND-160200","article-title":"Sarcomere Dysfunction in Nemaline Myopathy.","volume":"4","author":"J de Winter","year":"2017","journal-title":"J Neuromuscul Dis."},{"key":"ref-38","doi-asserted-by":"publisher","first-page":"246-68","DOI":"10.1093\/brain\/awu368","article-title":"Pathophysiological concepts in the congenital myopathies: blurring the boundaries, sharpening the focus.","volume":"138","author":"G Ravenscroft","year":"2015","journal-title":"Brain."},{"key":"ref-39","doi-asserted-by":"publisher","first-page":"59-62","DOI":"10.1038\/362059a0","article-title":"Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.","volume":"362","author":"D Rosen","year":"1993","journal-title":"Nature."},{"key":"ref-40","doi-asserted-by":"publisher","first-page":"703-8","DOI":"10.1086\/424760","article-title":"Mutations in the slow skeletal muscle fiber myosin heavy chain gene (MYH7) cause laing early-onset distal myopathy (MPD1).","volume":"75","author":"C Meredith","year":"2004","journal-title":"Am J Hum Genet."},{"key":"ref-41","doi-asserted-by":"publisher","first-page":"804-41","DOI":"10.1002\/ajmg.a.38418","article-title":"Treating pediatric neuromuscular disorders: The future is now.","volume":"176","author":"J Dowling","year":"2018","journal-title":"Am J Med Genet A."},{"key":"ref-42","doi-asserted-by":"publisher","first-page":"1-3","DOI":"10.1089\/nat.2016.0657","article-title":"FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga.","volume":"27","author":"A Aartsma-Rus","year":"2017","journal-title":"Nucleic Acid Ther."},{"key":"ref-43","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13023-018-0834-2","article-title":"Exon skipping for Duchenne muscular dystrophy: a systematic review and meta-analysis.","volume":"13","author":"Y Shimizu-Motohashi","year":"2018","journal-title":"Orphanet J Rare Dis."},{"key":"ref-44","doi-asserted-by":"publisher","first-page":"516-7","DOI":"10.1017\/cjn.2018.59","article-title":"Response to the Canadian Agency for Drugs and Technologies in Health and Institut national d'excellence en sant\u00e9 et en services sociaux decision regarding nusinersen for Spinal Muscular Atrophy.","volume":"45","author":"C Campbell","year":"2018","journal-title":"Can J Neurol Sci."},{"key":"ref-45","doi-asserted-by":"publisher","first-page":"123-5","DOI":"10.1001\/jamapediatrics.2017.4360","article-title":"Nusinersen for Spinal Muscular Atrophy: Are We Paying Too Much for Too Little?","volume":"172","author":"V Prasad","year":"2018","journal-title":"JAMA Pediatr."},{"key":"ref-46","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan8081","article-title":"Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy.","volume":"9","author":"L Amoasii","year":"2017","journal-title":"Sci Transl Med."},{"key":"ref-47","doi-asserted-by":"publisher","first-page":"86-91","DOI":"10.1126\/science.aau1549","article-title":"Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy.","volume":"362","author":"L Amoasii","year":"2018","journal-title":"Science."},{"key":"ref-48","doi-asserted-by":"publisher","first-page":"400-3","DOI":"10.1126\/science.aad5725","article-title":"Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy.","volume":"351","author":"C Long","year":"2016","journal-title":"Science."},{"key":"ref-49","doi-asserted-by":"publisher","first-page":"717-25","DOI":"10.1002\/ana.24619","article-title":"Modulating myosin restores muscle function in a mouse model of nemaline myopathy.","volume":"79","author":"J Lindqvist","year":"2016","journal-title":"Ann Neurol."},{"key":"ref-50","doi-asserted-by":"publisher","first-page":"1568-81","DOI":"10.1016\/j.ajpath.2016.02.008","article-title":"Treatment with ActRIIB-mFc Produces Myofiber Growth and Improves Lifespan in the Acta1 H40Y Murine Model of Nemaline Myopathy.","volume":"186","author":"J Tinklenberg","year":"2016","journal-title":"Am J Pathol."},{"key":"ref-51","doi-asserted-by":"publisher","first-page":"220ra10","DOI":"10.1126\/scitranslmed.3007523","article-title":"Gene therapy prolongs survival and restores function in murine and canine models of myotubular myopathy.","volume":"6","author":"M Childers","year":"2014","journal-title":"Sci Transl Med."},{"key":"ref-52","doi-asserted-by":"publisher","first-page":"1525-38","DOI":"10.1093\/hmg\/ddt003","article-title":"Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathy.","volume":"22","author":"M Lawlor","year":"2013","journal-title":"Hum Mol Genet."},{"key":"ref-53","doi-asserted-by":"publisher","first-page":"839-54","DOI":"10.1016\/j.ymthe.2017.02.004","article-title":"Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs.","volume":"25","author":"D Mack","year":"2017","journal-title":"Mol Ther."},{"key":"ref-54","doi-asserted-by":"publisher","first-page":"943-53","DOI":"10.1002\/mus.25658","article-title":"Long-term effects of systemic gene therapy in a canine model of myotubular myopathy.","volume":"56","author":"M Elverman","year":"2017","journal-title":"Muscle Nerve."},{"key":"ref-55","doi-asserted-by":"publisher","first-page":"1082-92","DOI":"10.1016\/j.ymthe.2018.02.008","article-title":"Single Intramuscular Injection of AAV-shRNA Reduces DNM2 and Prevents Myotubular Myopathy in Mice.","volume":"26","author":"H Tasfaout","year":"2018","journal-title":"Mol Ther."},{"key":"ref-56","doi-asserted-by":"publisher","first-page":"15661","DOI":"10.1038\/ncomms15661","article-title":"Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice.","volume":"8","author":"H Tasfaout","year":"2017","journal-title":"Nat Commun."},{"key":"ref-57","doi-asserted-by":"publisher","first-page":"239-53","DOI":"10.15252\/emmm.201707988","article-title":"Allele-specific silencing therapy for Dynamin 2-related dominant centronuclear myopathy.","volume":"10","author":"D Trochet","year":"2018","journal-title":"EMBO Mol Med."},{"key":"ref-58","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.1038\/mtna.2016.67","article-title":"Reprogramming the Dynamin 2 mRNA by Spliceosome-mediated RNA Trans-splicing.","volume":"5","author":"D Trochet","year":"2016","journal-title":"Mol Ther Nucleic Acids."},{"key":"ref-59","doi-asserted-by":"publisher","first-page":"282-95","DOI":"10.1093\/jnen\/nly002","article-title":"Intravenous Administration of a MTMR2-Encoding AAV Vector Ameliorates the Phenotype of Myotubular Myopathy in Mice.","volume":"77","author":"N Dani\u00e8le","year":"2018","journal-title":"J Neuropathol Exp Neurol."},{"key":"ref-60","doi-asserted-by":"publisher","first-page":"3736-48","DOI":"10.1093\/hmg\/ddx258","article-title":"Expression of the neuropathy-associated MTMR2 gene rescues MTM1-associated myopathy.","volume":"26","author":"M Raess","year":"2017","journal-title":"Hum Mol Genet."},{"key":"ref-61","doi-asserted-by":"publisher","first-page":"3613-25","DOI":"10.1172\/JCI86841","article-title":"PIK3C2B inhibition improves function and prolongs survival in myotubular myopathy animal models.","volume":"126","author":"N Sabha","year":"2016","journal-title":"J Clin Invest."},{"key":"ref-62","doi-asserted-by":"publisher","first-page":"1115-27","DOI":"10.1093\/brain\/aws036","article-title":"Oxidative stress and successful antioxidant treatment in models of RYR1-related myopathy.","volume":"135","author":"J Dowling","year":"2012","journal-title":"Brain."},{"key":"ref-63","doi-asserted-by":"publisher","first-page":"638-48","DOI":"10.1093\/hmg\/ddx431","article-title":"Myostatin inhibition using mRK35 produces skeletal muscle growth and tubular aggregate formation in wild type and TgACTA1D286G nemaline myopathy mice.","volume":"27","author":"J Tinklenberg","year":"2018","journal-title":"Hum Mol Genet."},{"key":"ref-64","article-title":"A new treatment for congenital nonprogressive nemaline myopathy.","volume":"4","author":"D Kalita","year":"1989","journal-title":"J Orthomol Med."},{"key":"ref-65","doi-asserted-by":"publisher","first-page":"609-13","DOI":"10.1177\/0883073807309794","article-title":"Dietary L-tyrosine supplementation in nemaline myopathy.","volume":"23","author":"M Ryan","year":"2008","journal-title":"J Child Neurol."},{"key":"ref-66","doi-asserted-by":"publisher","first-page":"3516-29","DOI":"10.1093\/brain\/awr274","article-title":"Hypertrophy and dietary tyrosine ameliorate the phenotypes of a mouse model of severe nemaline myopathy.","volume":"134","author":"M Nguyen","year":"2011","journal-title":"Brain."},{"key":"ref-67","doi-asserted-by":"publisher","first-page":"11490","DOI":"10.1038\/s41598-018-29437-z","article-title":"L-tyrosine supplementation does not ameliorate skeletal muscle dysfunction in zebrafish and mouse models of dominant skeletal muscle \u03b1-actin nemaline myopathy.","volume":"8","author":"A Messineo","year":"2018","journal-title":"Sci Rep."},{"key":"ref-68","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40478-018-0546-9","article-title":"Testing of therapies in a novel nebulin nemaline myopathy model demonstrate a lack of efficacy.","volume":"6","author":"T Sztal","year":"2018","journal-title":"Acta Neuropathol Commun."},{"key":"ref-69","doi-asserted-by":"publisher","first-page":"175-84","DOI":"10.1002\/ana.21035","article-title":"Nemaline myopathy caused by absence of alpha-skeletal muscle actin.","volume":"61","author":"K Nowak","year":"2007","journal-title":"Ann Neurol."},{"key":"ref-70","doi-asserted-by":"publisher","first-page":"903-15","DOI":"10.1083\/jcb.200812132","article-title":"Rescue of skeletal muscle alpha-actin-null mice by cardiac (fetal) alpha-actin.","volume":"185","author":"K Nowak","year":"2009","journal-title":"J Cell Biol."},{"key":"ref-71","doi-asserted-by":"publisher","first-page":"e1007212","DOI":"10.1371\/journal.pgen.1007212","article-title":"Genetic compensation triggered by actin mutation prevents the muscle damage caused by loss of actin protein.","volume":"14","author":"T Sztal","year":"2018","journal-title":"PLoS Genet."},{"key":"ref-72","doi-asserted-by":"publisher","first-page":"2307-15","DOI":"10.1001\/jama.1993.03510190063028","article-title":"Tay-Sachs disease--carrier screening, prenatal diagnosis, and the molecular era. An international perspective, 1970 to 1993. The International TSD Data Collection Network.","volume":"270","author":"M Kaback","year":"1993","journal-title":"JAMA."},{"key":"ref-73","doi-asserted-by":"publisher","first-page":"e1-e12","DOI":"10.1038\/ejhg.2015.271","article-title":"Responsible implementation of expanded carrier screening.","volume":"24","author":"L Henneman","year":"2016","journal-title":"Eur J Hum Genet."},{"key":"ref-74","doi-asserted-by":"publisher","first-page":"734-42","DOI":"10.1001\/jama.2016.11139","article-title":"Modeled Fetal Risk of Genetic Diseases Identified by Expanded Carrier Screening.","volume":"316","author":"I Haque","year":"2016","journal-title":"JAMA."},{"key":"ref-75","doi-asserted-by":"publisher","first-page":"e35-e40","DOI":"10.1097\/AOG.0000000000001951","article-title":"Committee Opinion No. 690: Carrier Screening in the Age of Genomic Medicine.","volume":"129","year":"2017","journal-title":"Obstet Gynecol."},{"key":"ref-76","doi-asserted-by":"publisher","first-page":"203-6","DOI":"10.1038\/gim.2015.55","article-title":"The Israeli national population program of genetic carrier screening for reproductive purposes.","volume":"18","author":"J Zlotogora","year":"2016","journal-title":"Genet Med."},{"key":"ref-77","doi-asserted-by":"publisher","first-page":"744-52","DOI":"10.1136\/jmedgenet-2018-105362","article-title":"Measuring the impact of genetic knowledge on intentions and attitudes of the community towards expanded preconception carrier screening.","volume":"55","author":"R Ong","year":"2018","journal-title":"J Med Genet."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/7-1921\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/7-1921\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/7-1921\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T12:11:27Z","timestamp":1553861487000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/7-1921\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,11]]},"references-count":77,"URL":"https:\/\/doi.org\/10.12688\/f1000research.16422.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.17943.r41260","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.17943.r41259","asserted-by":"subject"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,11]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/7-1921\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.17943.r41260, Edmar Zanoteli, Department of Neurology, School of Medicine, University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil, 11 Dec 2018, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/7-1921\/v1#referee-response-41260","order":0,"name":"referee-response-41260","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.17943.r41259, Dae-Seong Kim, Department of Neurology, Pusan National University Yangsan Hospital, Yangsan, South Korea, 11 Dec 2018, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/7-1921\/v1#referee-response-41259","order":1,"name":"referee-response-41259","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"Gianina Ravenscroft is supported by a National Health and Medical Research Council (NHMRC) Career Development Fellowship (APP1122952). Nigel G. Laing is supported by an NHMRC Principal Research Fellowship (APP1117510). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}